ID: ALA5270044

Max Phase: Preclinical

Molecular Formula: C24H23Cl3N2O

Molecular Weight: 425.36

Representations

Canonical SMILES:  Cc1cccc(CN2CC=C(/C=C/c3ccc4c(Cl)cc(Cl)c(O)c4n3)CC2)c1.Cl

Standard InChI:  InChI=1S/C24H22Cl2N2O.ClH/c1-16-3-2-4-18(13-16)15-28-11-9-17(10-12-28)5-6-19-7-8-20-21(25)14-22(26)24(29)23(20)27-19;/h2-9,13-14,29H,10-12,15H2,1H3;1H/b6-5+;

Standard InChI Key:  WECGJPLOFASEPS-IPZCTEOASA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 425.36

Molecular Weight (Monoisotopic): 424.1109

AlogP: 6.40

#Rotatable Bonds: 4

Polar Surface Area: 36.36

Molecular Species: BASE

HBA: 3

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 6.89

CX Basic pKa: 8.81

CX LogP: 5.10

CX LogD: 5.05

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.53

Np Likeness Score: -0.87

References

1. Li X, Li T, Zhang P, Li X, Lu L, Sun Y, Zhang B, Allen S, White L, Phillips J, Zhu Z, Yao H, Xu J..  (2022)  Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease.,  244  [PMID:36257284] [10.1016/j.ejmech.2022.114841]

Source

Source(1):

• Scientific Literature